Search for: "BRISTOL MYERS SQUIBB" Results 201 - 220 of 867
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Dec 2017, 10:48 pm by GJEL
The remaining manufacturers, including Bristol-Myers Squibb, ultimately settled for $3.4 billion, and Dow Corning resolved its claims in bankruptcy court. [read post]
12 Dec 2017, 3:01 am by Walter Olson
., JAMA Cardiology, Cristina Boccuti and Giselle Casillas, Kaiser Family Foundation] Litigation tourism model that has done well for plaintiff’s bar now circling drain after Supreme Court’s Bauman, Bristol-Myers Squibb decisions [Jim Beck, Drug & Device Law, more, yet more; related on West Virginia, and from Michelle Yeary on choice of law and forum non conveniens] “FDA Commissioner Scott Gottlieb Goes to Bat For Evidence-Based Opioid… [read post]
9 Nov 2017, 4:00 am by Alan Macek
Earlier this year, the Federal Court of Appeal, in Bristol-Myers Squibb Canada Co. v. [read post]
5 Nov 2017, 8:58 pm by Patent Docs
Patent and Trademark Office) - Alexandria, VA November 7, 2017 - "Personal Jurisdiction After Bristol-Myers Squibb: Unresolved Issues, Shifting Plaintiff Strategies" (Strafford) - 1:00 to 2:30 pm (EST) November 9, 2017 - "Leveraging USPTO Examiner Count System: Efficiently Prosecuting Patents, Lowering Prosecution Costs" (Strafford) - 1:00 to 2:30 pm (EST) November 9, 2017 - "Patent Drafting: Trends, Reality and Avoiding Rejections"… [read post]
4 Nov 2017, 9:08 pm by Patent Docs
Strafford will be offering a webcast entitled "Personal Jurisdiction After Bristol-Myers Squibb: Unresolved Issues, Shifting Plaintiff Strategies" on November 7, 2017 from 1:00 to 2:30 pm (EST). [read post]
24 Oct 2017, 7:00 am by Altman & Altman
Out-of-State Restrictions In a case involving Bristol-Myers Squibb, the Missouri Supreme Court ruled in June 2017 that courts only have jurisdiction over an out-of-state claim if there exists an “affiliation between the forum and the underlying controversy, principally, [an] activity or an occurrence that takes place in the forum State. [read post]
10 Oct 2017, 11:35 am by Caroline Cornell
If you are Bristol-Myers Squibb with its Abilify, you spend millions on consumer and physician advertising, stay silent about the drug’s risks, and trump up its benefits. [read post]
10 Oct 2017, 3:59 am by Broc Romanek
Tune in today for the webcast – “E&S Disclosures: The In-House Perspective” – to hear National Vision’s Jared Brandman, Davis Polk’s Ning Chiu, Bristol-Myers Squibb’s Kate Kelly, Apple’s Jung-Kyu McCann and Clorox’s Stephanie Tang discuss environmental & social disclosure issues – in both SEC filings & other types of filings. [read post]
24 Sep 2017, 2:22 pm by Nancy E. Halpern, D.V.M.
., Professor and IACUC Chair, Rutgers University Elizabeth Dodemaide, BVSc, MA, MANZCVS, Director Comparative Medicine Resources, Rutgers University Gregory Reinhard, DVM, Director, Animal Welfare, University of Pennsylvania Strategies to Enhance Animal Welfare Compliance Monitoring Presenters: Pharmaceutical: Lisa Stanislawczyk, Bristol-Myers Squibb, CRO: Mary Ann Jacobs, Envigo Academic: Greg Reinhard, MBA, DVM, University of Pennsylvania, The Role of the Statistician… [read post]
4 Sep 2017, 9:05 pm by Walter Olson
” [Nicholas Malfitano, Penn Record/Forbes, earlier on Bristol-Myers Squibb v. [read post]
1 Sep 2017, 9:59 am by Bekman, Marder & Adkins, L.L.C.
In an 82-page opinion yesterday, a federal judge permitted the claims of more than 800 Guatemalan victims of non-consensual human experimentation, represented by Bekman, Marder & Adkins, to proceed against Defendants, Johns Hopkins, The Rockefeller Foundation, and Bristol-Myers Squibb. [read post]